Low DLCO/SB Linked to Faster SSc Progression - Summary - MDSpire
From the Journals

Low DLCO/SB Linked to Faster SSc Progression

Lower gas transfer at baseline was associated with higher unadjusted progression rates and shorter time to transition, though multivariable analysis did not identify independent predictors

Share

A retrospective longitudinal study involving 73 patients revealed that lower baseline diffusing capacity of the lungs for carbon monoxide (DLCO/SB) is linked to a higher risk of progressing to systemic sclerosis (SSc) and a quicker transition in individuals with early-stage disease. Over five years, 12% of patients progressed to definite SSc, with notably higher rates among those with DLCO/SB below 70%. Other factors such as SSc-specific antibodies also played a role in progression, but no variable emerged as a significant independent predictor.

Original Source(s)

Low DLCO/SB Linked to Faster SSc Progression

  • by Andrea Surnit

  • April 6, 2026

Related Content

Reproductive Health Framework for Care

Narrative review and commentary proposes framework to address care gaps beyond disease control

UCI Health lupus clinical trial offers hope to patients with the disease

Patient experinces life-changing improvements thanks to CAR T-cell therapy.

  • by

  • April 8, 2026

  • 1 min
RA App Overestimates Active Disease

Self-reported joint counts showed modest agreement with physician assessments and tended to overestimate active disease in a community-based study